AT306713B - Verfahren zur Herstellung neuer α-Carboline und ihrer Salze - Google Patents

Verfahren zur Herstellung neuer α-Carboline und ihrer Salze

Info

Publication number
AT306713B
AT306713B AT736571A AT736571A AT306713B AT 306713 B AT306713 B AT 306713B AT 736571 A AT736571 A AT 736571A AT 736571 A AT736571 A AT 736571A AT 306713 B AT306713 B AT 306713B
Authority
AT
Austria
Prior art keywords
carbolines
salts
new
production
Prior art date
Application number
AT736571A
Other languages
English (en)
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Application granted granted Critical
Publication of AT306713B publication Critical patent/AT306713B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT736571A 1968-03-15 1969-03-14 Verfahren zur Herstellung neuer α-Carboline und ihrer Salze AT306713B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1273268A GB1268773A (en) 1968-03-15 1968-03-15 NOVEL alpha-CARBOLINE DERIVATIVES, THE PREPARATION THEREOF AND COMPOSITIONS CONTAINING THE SAME

Publications (1)

Publication Number Publication Date
AT306713B true AT306713B (de) 1973-04-25

Family

ID=10010080

Family Applications (2)

Application Number Title Priority Date Filing Date
AT736571A AT306713B (de) 1968-03-15 1969-03-14 Verfahren zur Herstellung neuer α-Carboline und ihrer Salze
AT253269A AT305277B (de) 1968-03-15 1969-03-14 Verfahren zur Herstellung neuer α-Carboline und ihrer Salze

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT253269A AT305277B (de) 1968-03-15 1969-03-14 Verfahren zur Herstellung neuer α-Carboline und ihrer Salze

Country Status (9)

Country Link
AT (2) AT306713B (de)
BE (1) BE729854A (de)
CH (1) CH529155A (de)
DE (1) DE1913124A1 (de)
FR (1) FR2004000A1 (de)
GB (1) GB1268773A (de)
IE (1) IE32706B1 (de)
NL (1) NL6903974A (de)
SE (1) SE370399B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4952584A (en) * 1986-01-11 1990-08-28 Beecham Group P.L.C. 9H-pyrido[2,B-8]indole-3-carboxylic acid ester compounds having useful pharmaceutical activity
GB8600651D0 (en) * 1986-01-11 1986-02-19 Beecham Group Plc Compounds
US6147085A (en) * 1999-04-01 2000-11-14 Neurogen Corporation Aminoalkyl substituted 9H-pyridino[2,3-b] indole and 9H-pyrimidino[4,5-b] indole derivatives
US8119655B2 (en) 2005-10-07 2012-02-21 Takeda Pharmaceutical Company Limited Kinase inhibitors
JP2010505962A (ja) 2006-10-09 2010-02-25 武田薬品工業株式会社 キナーゼ阻害剤
EP2161271A1 (de) * 2008-09-08 2010-03-10 Università Degli Studi Di Milano - Bicocca Alpha-Carbolin-Hemmer von NMP-ALK, RET und Bcr-Abl
WO2016037106A1 (en) * 2014-09-05 2016-03-10 Allosteros Therapeutics, Inc CaMKII INHIBITORS AND USES THEREOF

Also Published As

Publication number Publication date
SE370399B (de) 1974-10-14
IE32706B1 (en) 1973-10-31
IE32706L (en) 1969-09-15
GB1268773A (en) 1972-03-29
BE729854A (de) 1969-09-15
NL6903974A (de) 1969-09-17
FR2004000A1 (de) 1969-11-14
AT305277B (de) 1973-02-26
CH529155A (de) 1972-10-15
DE1913124A1 (de) 1969-10-02

Similar Documents

Publication Publication Date Title
AT296289B (de) Verfahren zur Herstellung neuer Imidazolderivate und ihrer Salze
AT304533B (de) Verfahren zur Herstellung neuer α-Carboline und ihrer Salze
AT300788B (de) Verfahren zur Herstellung neuer Imidazolderivate und ihrer Salze
AT310738B (de) Verfahren zur Herstellung neuer Benzimidazol-derivate und ihrer Salze
AT323186B (de) Verfahren zur herstellung neuer dihydropyridazone und ihrer salze
AT323152B (de) Verfahren zur herstellung neuer indolderivate und ihrer salze
AT314531B (de) Verfahren zur Herstellung neuer 2-Phenylamino-imidazolidine und ihrer Salze
AT318649B (de) Verfahren zur Herstellung neuer Ureidophenoxy-2-hydroxy-3-aminopropane und ihrer Salze
AT295529B (de) Verfahren zur Herstellung neuer 5,6-Dimethoxy-indazol-3-carbonsäureamide und ihrer Salze
AT289108B (de) Verfahren zur Herstellung neuer Thiazolylbenzoesäurederivate und ihrer Salze
AT297701B (de) Verfahren zur Herstellung neuer Bistriazolyl-bisphenyl-methanen und deren Salze
AT309460B (de) Verfahren zur Herstellung neuer Phenacetylguanidine und ihrer Säureadditionssalze
ATA943273A (de) Verfahren zur herstellung neuer substituierter 2-phenylamino-imidazoline und ihrer saeureadditionssalze
AT306713B (de) Verfahren zur Herstellung neuer α-Carboline und ihrer Salze
AT289091B (de) Verfahren zur Herstellung neuer 4-Cyano-4-phenyl-aminocyclohexane und deren Salze
AT262259B (de) Verfahren zur Herstellung neuer Styryläthanolamine und ihrer Salze
AT293395B (de) Verfahren zur Herstellung neuer basischer Äther und deren Salze
AT292713B (de) Verfahren zur Herstellung neuer basischer Äther und deren Salze
AT304554B (de) Verfahren zur Herstellung neuer Pyridin-Verbindungen und ihrer Säureadditionssalze
AT293414B (de) Verfahren zur Herstellung neuer Benzomorphanderivate und ihrer Salze
AT278022B (de) Verfahren zur Herstellung neuer Diphenyl-pyridazone und ihrer Salze
AT299199B (de) Verfahren zur Herstellung neuer Benzodioxanderivate und ihrer Salze
AT290527B (de) Verfahren zur Herstellung neuer Bisimidazolyl-bisphenylmethane und ihrer Salze
CH556840A (de) Verfahren zur herstellung neuer indolderivate und ihrer salze.
AT286283B (de) Verfahren zur Herstellung neuer Cumarinderivate und ihrer Salze

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee